Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1316
H.R.1316: Prescription Drug Price Transparency Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced March 2, 2017
- Latest Major Action April 5, 2017
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
56 (14 Democrats, 42 Republicans)
Bill Version
- Introduced in House - March 2, 2017
Bill Summary
Prescription Drug Price Transparency Act This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
April 5, 2017 |
Referred to the Subcommittee on Military Personnel.
|
March 17, 2017 |
Referred to the Subcommittee on Health.
|
March 15, 2017 |
Referred to the Subcommittee on Health.
|
March 2, 2017 |
Referred to House Oversight and Government Reform
|
March 2, 2017 |
Referred to House Armed Services
|
March 2, 2017 |
Referred to House Ways and Means
|
March 2, 2017 |
Referred to House Energy and Commerce
|
March 2, 2017 |
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
March 2, 2017 |
Introduced in the House by Doug Collins (R-Ga.) |